Information  X 
Enter a valid email address

EPIC/TIDM matching '0EIT'

Date
Time Source
Company
Announcement
31 Jul 2018 7:00 am GNW   Factsheet TiGenix (0EIT) Takeda Completes its Acquisition of TiGenix Following Expiration of the Squeeze-out Period
23 Jul 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
06 Jul 2018 6:00 am GNW   Factsheet TiGenix (0EIT) Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid
02 Jul 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency Information
27 Jun 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
22 Jun 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
19 Jun 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
14 Jun 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) Transparency notification pursuant to Article 14 of the Law of May 2, 2007
13 Jun 2018 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix announces a change in its Board of Directors and its Management Team
06 Jun 2018 6:00 am GNW   Factsheet TiGenix (0EIT) Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period
28 May 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
14 May 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
08 May 2018 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHOLDERS' MEETING TO BE HELD ON 7 JUNE 2018
13 Apr 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
12 Apr 2018 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix reports 2017 full year results
10 Apr 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
30 Mar 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
23 Mar 2018 5:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe
06 Feb 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency Information
31 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
26 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
19 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency Information
18 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
16 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
15 Jan 2018 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601
12 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
11 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) TiGenix: Transparency Information
05 Jan 2018 6:30 am GNW   Factsheet TiGenix (0EIT) Takeda announces its intention to acquire TiGenix
03 Jan 2018 9:00 pm GNW   Factsheet TiGenix (0EIT) Transparency notification pursuant to Article 14 of the Law of May 2, 2007
20 Dec 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform
15 Dec 2017 12:11 pm GNW   Factsheet TiGenix (0EIT) Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease
14 Dec 2017 11:21 pm GNW   Factsheet TiGenix (0EIT) Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae
24 Nov 2017 9:00 pm GNW   Factsheet TiGenix (0EIT) JPMorgan Chase & Co notifies 3.12% shareholding in TiGenix
20 Nov 2017 8:31 am GNW   Factsheet TiGenix (0EIT) TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting
16 Nov 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix announces approval of trade name for lead development candidate Cx601 in Europe
06 Nov 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix announces partial conversion of bonds
02 Nov 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix strengthens European IP protection around lead development program Cx601
31 Oct 2017 6:01 am GNW   Factsheet TiGenix (0EIT) TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure
23 Oct 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601
05 Oct 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting
02 Oct 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix to host Analyst and Investor Event in New York City
28 Sep 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix to participate and present at key investor and business development meetings
19 Sep 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix Business and Financial Update for the First Half 2017
12 Sep 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix strengthens US operations with senior appointments
05 Sep 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix obtains commercial production license for expanded manufacturing facility
23 Jun 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix to present at the 7th TERMIS-EU Conference in Davos, Switzerland
20 Jun 2017 6:00 am GNW   Factsheet TiGenix (0EIT) Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn's disease patients
15 Jun 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn's Disease and Ulcerative Colitis
13 Jun 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix Launches Global Phase III Trial for Cx601
12 Jun 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix announces final equity payment for cardiac platform acquisition
01 Jun 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix to present at the Jefferies 2017 Global Healthcare Conference in New York
31 May 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure
11 May 2017 6:03 am GNW   Factsheet TiGenix (0EIT) TiGenix to present at Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas
10 May 2017 6:02 am GNW   Factsheet TiGenix (0EIT) TiGenix to present at the Crohn's and Colitis Foundation's Novel Technologies in Inflammatory Bowel Disease workshop in New York
04 May 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week
02 May 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHOLDERS' MEETING TO BE HELD ON 1 JUNE 2017
06 Apr 2017 6:01 am GNW   Factsheet TiGenix (0EIT) TiGenix reports 2016 full year results
05 Apr 2017 6:01 am GNW   Factsheet TiGenix (0EIT) TiGenix to participate in key investor conferences in April 2017
13 Mar 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction
09 Mar 2017 6:00 am GNW   Factsheet TiGenix (0EIT) TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t